Celldex Therapeutics CLDX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$78.69M-46.3% | -$81.32M-72.7% | -$67.04M-59.2% | -$56.6M-57.9% | -$53.8M-64.0% | ||
| $854K-1.5% | $816K-0.4% | $824K+4.8% | $873K+9.5% | $867K+11.9% | ||
| $8.52M-8.5% | $8.91M-8.9% | $8.8M-8.5% | $9.19M+20.3% | $9.32M+29.4% | ||
| -$3K+25.0% | $0+100% | -$6K-50.0% | -$2K— | -$4K+50.0% | ||
| -$287K+96.7% | $4.6M-42.4% | $13.06M+94.8% | $2.09M+21.7% | -$8.72M-82.3% | ||
| -$6.28M-239% | -$8.47M— | —— | -$1.17M— | -$1.85M-130% | ||
| -$1.36M-125% | —— | -$410K+84.8% | -$1.12M-77.2% | -$604K+58.9% | ||
| -$1.79M-590% | $1.93M+1,366% | $0+100% | -$974K+14.3% | $364K+747% | ||
| -$65.59M-20.6% | -$63.94M-96.9% | -$48.63M+12.1% | -$44.01M-50.0% | -$54.37M-33.8% | ||
| $1.64M+518% | $1.28M+69.4% | $440K-19.3% | $728K+166% | $265K-23.0% | ||
| $72.12M+67.9% | $55.43M— | $60.85M— | $49.85M+207% | $42.95M+114% | ||
| $327K+61.9% | —— | —— | —— | $202K-100.0% | ||
| $327K+61.9% | $1.35M+249% | $774K-37.5% | $63K-98.3% | $202K-100.0% | ||
| $6.86M+161% | —— | $12.99M— | —— | -$11.22M-114% | ||
| $630K-72.2% | $882K-73.8% | $1.02M-76.5% | $1.69M-64.4% | $2.27M-31.6% | ||
| -$1.79M-590% | $1.93M+1,366% | $0+100% | -$974K+14.3% | $364K+747% | ||
| $2.08M+214% | $3.99M+65.7% | $64K-97.3% | -$1.11M-146% | $662K-72.5% | ||
| -$6.28M-239% | -$8.47M— | —— | -$1.17M— | -$1.85M-130% | ||
| -$78.69M-46.3% | -$81.32M-72.7% | -$67.04M-59.2% | -$56.6M-57.9% | -$53.8M-64.0% | ||
| $327K+61.9% | $1.35M+249% | $774K-37.5% | $63K-98.3% | $202K-94.7% | ||
| $953K+89.1% | —— | $423K+96.7% | —— | $504K+380% | ||
| -$67.23M-23.0% | -$65.22M-96.3% | -$49.07M+12.2% | -$44.73M-51.1% | -$54.64M-33.3% | ||
| -$67.23M-23.0% | -$65.22M-96.3% | -$49.07M+12.2% | -$44.73M-51.1% | -$54.64M-33.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Celldex Therapeutics's cash flow data come from?
- Every line is extracted from Celldex Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.